Galapagos NV
GLPG
#4563
Rank
โ‚ฌ1.81 B
Marketcap
27,13ย โ‚ฌ
Share price
-0.57%
Change (1 day)
6.57%
Change (1 year)

Galapagos NV (GLPG) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ1.07 Billion

According to Galapagos NV's latest financial reports the company's total liabilities are โ‚ฌ1.07 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galapagos NV - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ1.23 B-20.68%
2023-12-31โ‚ฌ1.56 B-29.28%
2022-12-31โ‚ฌ2.20 B-13.39%
2021-12-31โ‚ฌ2.54 B-16.33%
2020-12-31โ‚ฌ3.04 B-4.56%
2019-12-31โ‚ฌ3.19 B1317.53%
2018-12-31โ‚ฌ0.22 B-17.88%
2017-12-31โ‚ฌ0.27 B-15.51%
2016-12-31โ‚ฌ0.32 B318.81%
2015-12-31โ‚ฌ77.51 M20.49%
2014-12-31โ‚ฌ64.33 M-46.5%
2013-12-31โ‚ฌ0.12 B2.87%
2012-12-31โ‚ฌ0.11 B173.86%
2011-12-31โ‚ฌ42.67 M-6.11%
2010-12-31โ‚ฌ45.45 M30.49%
2009-12-31โ‚ฌ34.83 M0.96%
2008-12-31โ‚ฌ34.5 M-31.13%
2007-12-31โ‚ฌ50.09 M-13.78%
2006-12-31โ‚ฌ58.1 M184.45%
2005-12-31โ‚ฌ20.42 M289.38%
2004-12-31โ‚ฌ5.24 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AstraZeneca
AZN
โ‚ฌ58.82 B 5,379.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚ฌ97.51 B 8,984.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ56.71 B 5,182.97%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚ฌ117.23 B 10,821.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
โ‚ฌ0.10 B-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ28.27 B 2,533.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ28.00 B 2,508.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚ฌ52.63 B 4,803.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ66.68 B 6,112.06%๐Ÿ‡บ๐Ÿ‡ธ USA